Derivation of CYP3A4 and CYP2B6 degradation rate constants in primary human hepatocytes: A siRNA-silencing-based approach-Reference-Cited by-同舟云学术

Derivation of CYP3A4 and CYP2B6 degradation rate constants in primary human hepatocytes: A siRNA-silencing-based approach

Published:2018-08 Issue:4 Volume:33 Page:179-187
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Chan Christina Y.S.,Roberts Owain,Rajoli Rajith K.R.,Liptrott Neill J.^ORCID,Siccardi Marco,Almond Lisa,Owen Andrew

Funder

Medical Research Council

Simcyp Limited (a Certara company)

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference64 articles.

1. Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes;Tanaka;J Clin Pharm Ther,1998

2. Perspective in vitro and in vivo induction of cytochrome P450: a survey of the current practices and recommendations: a pharmaceutical;Chu;Pharmacology,2009

3. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data;Rostami-Hodjegan;Nat Rev Drug Discov,2007

4. Clinical-pharmacological strategies to assess drug interaction potential during drug development;Kuhlmann;Drug Saf,2001

5. Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach;Yeo;Expert Rev Clin Pharmacol,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Trial Data-Driven Risk Assessment of Drug–Drug Interactions: A Rapid and Accurate Decision-Making Tool;Clinical Pharmacokinetics;2024-08

2. Preclinical development of an EP2 antagonist for post-seizure cognitive deficits;Neuropharmacology;2023-02

3. A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS‐114;CPT: Pharmacometrics & Systems Pharmacology;2021-12-23

4. Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast Cancer;Clinical Pharmacology & Therapeutics;2021-11-06

5. Expression dynamics of pregnane X receptor-controlled genes in 3D primary human hepatocyte spheroids;Archives of Toxicology;2021-10-23